Akademik Veri Yönetim Sistemi
International Ocular Inflammation Society 2021 Congress, 2 - 05 Aralık 2021, ss.5
Purpose To report clinical characteristics and treatment of acute idiopathic hemorrhagic
retinal vasculitis (AIHRV)
Methods Records of 10 patients (7 female, 3 male) with AIHRV in 12 eyes seen between
2012-2018 were reviewed.
Results
Mean age at presentation was 32±5 years. Mean LogMAR visual acuity (VA) was
1.5±0.8, mean intraocular pressure (IOP) was 10.8±3.3, mean Nare value was
152.6±237.8ph/ms, mean central macular thickness (CMT) was 709.5±266.3 at
presentation. All patients had extensive preretinal and/or subretinal
hemorrhages and vascular sheathing. Fluorescein angiography was performed in
7 patients, showing retinal ischemia in 6 and neovascularization in 2 eyes.
Serological tests, hematologic and rheumatologic examination were unrewarding
in all. Mean follow-up was 13.5±9.9 months. 9 patients received systemic
corticosteroids. Adjunct local corticosteroids and/or intravitreal anti-VEGF
injections were performed when needed. 2 patients with macular edema received
Interferon alpha-2a, 2 patients received empirical oral valacyclovir and 1 patient
received azathioprine. Retinal laser photocoagulation was performed in 8 eyes.
Ocular complications were vitreous hemorrhage in 2 and increased IOP in 8
patients, including 2 with neovascular glaucoma. At [nal visit, mean LogMAR VA
was 0.8±0.8, mean IOP was 15.9±3.8, mean Nare was 22.8±30.9ph/ms, mean
CMT was 272.7±70.8.
Conclusion
AIHRV is a challenging condition with unknown etiology and there is no speci[c
treatment. Close follow-up is required for early detection and treatment of ocular
complications.